| Reference |
|---|
Arakélian L, Lion J, Churlaud G, Bargui R, Thierry B, Mutabazi E, et al. Endothelial CD34 expression and regulation of immune cell response in-vitro. Sci Rep. 2023;13:13512 pubmed publisher |
Weng C, Lee M, Chao W, Lin Y, Chou C, Chen M, et al. Airway epithelium IgE-FcεRI cross-link induces epithelial barrier disruption in severe T2-high asthma. Mucosal Immunol. 2023;16:685-698 pubmed publisher |
Szczepanik Ku x142 ak P, Michalska Jakubus M, Kowal M, Krasowska D. Serum Levels of Selected IL-1 Family Cytokines in Patients with Morphea. J Clin Med. 2022;11: pubmed publisher |
Chen W, Chen S, Yan C, Zhang Y, Zhang R, Chen M, et al. Allergen protease-activated stress granule assembly and gasdermin D fragmentation control interleukin-33 secretion. Nat Immunol. 2022;: pubmed publisher |
Rasheed K, Moens U, Policastro B, Johnsen J, Koljonen V, Sihto H, et al. The Merkel Cell Polyomavirus T-Antigens and IL-33/ST2-IL1RAcP Axis: Possible Role in Merkel Cell Carcinoma. Int J Mol Sci. 2022;23: pubmed publisher |
Mai E, Chan J, Goon L, Ego B, Bevers J, Wong T, et al. Development of an ultra-sensitive human IL-33 biomarker assay for age-related macular degeneration and asthma drug development. J Transl Med. 2021;19:517 pubmed publisher |
Zhang X, Bi K, Tu X, Zhang Q, Cao Q, Liang Y, et al. Interleukin-33 as an early predictor of cetuximab treatment efficacy in patients with colorectal cancer. Cancer Med. 2021;10:8338-8351 pubmed publisher |
Kuzumi A, Yoshizaki A, Matsuda K, Kotani H, Norimatsu Y, Fukayama M, et al. Interleukin-31 promotes fibrosis and T helper 2 polarization in systemic sclerosis. Nat Commun. 2021;12:5947 pubmed publisher |
Jeican I, Gheban D, Barbu Tudoran L, Inișca P, Albu C, Ilies M, et al. Respiratory Nasal Mucosa in Chronic Rhinosinusitis with Nasal Polyps versus COVID-19: Histopathology, Electron Microscopy Analysis and Assessing of Tissue Interleukin-33. J Clin Med. 2021;10: pubmed publisher |
He X, Howard B, Liu Y, Neumann A, Li L, Menon N, et al. LYSMD3: A mammalian pattern recognition receptor for chitin. Cell Rep. 2021;36:109392 pubmed publisher |
Mado H, Adamczyk Sowa M, Bartman W, Wierzbicki K, Tadeusiak B, Sowa P. Plasma Interleukin-33 level in relapsing-remitting multiple sclerosis. Is it negatively correlated with central nervous system lesions in patients with mild disability?. Clin Neurol Neurosurg. 2021;206:106700 pubmed publisher |
Zhou W, Zhang J, Toki S, Goleniewska K, Norlander A, Newcomb D, et al. COX Inhibition Increases Alternaria-Induced Pulmonary Group 2 Innate Lymphoid Cell Responses and IL-33 Release in Mice. J Immunol. 2020;205:1157-1166 pubmed publisher |
Tanosaki T, Kabata H, Matsusaka M, Miyata J, Masaki K, Mochimaru T, et al. Clinical characteristics of patients with not well-controlled severe asthma in Japan: Analysis of the Keio Severe Asthma Research Program in Japanese population (KEIO-SARP) registry. Allergol Int. 2021;70:61-67 pubmed publisher |
Saresella M, Marventano I, Piancone F, La Rosa F, Galimberti D, Fenoglio C, et al. IL-33 and its decoy sST2 in patients with Alzheimer's disease and mild cognitive impairment. J Neuroinflammation. 2020;17:174 pubmed publisher |
Borsky P, Fiala Z, Andrys C, Beránek M, Hamakova K, Malkova A, et al. Alarmins HMGB1, IL-33, S100A7, and S100A12 in Psoriasis Vulgaris. Mediators Inflamm. 2020;2020:8465083 pubmed publisher |
Zhuang Y, Chen Y, Zhou S, Peng H, Chen Y, Li D. High plasma levels of pro-inflammatory factors interleukin-17 and interleukin-23 are associated with poor outcome of cardiac-arrest patients: a single center experience. BMC Cardiovasc Disord. 2020;20:170 pubmed publisher |
Han M, Kim S, Oh I, Kim Y, Lee J. Serum IL-1β can be a biomarker in children with severe persistent allergic rhinitis. Allergy Asthma Clin Immunol. 2019;15:58 pubmed publisher |
Al Aarag A, Kamel M, Abdelgawad E, Abo Youssef S, Moussa H, Elnaggar M, et al. Diagnostic role of interleukin -33 in the differentiation of pleural effusions especially tuberculous and malignant effusions. BMC Pulm Med. 2019;19:114 pubmed publisher |
Ohta N, Yasudo H, Mizutani M, Matsushige T, Fukano R, Kittaka S, et al. Serum soluble ST2 as a marker of renal scar in pediatric upper urinary tract infection. Cytokine. 2019;120:258-263 pubmed publisher |
Watanabe M, Nakamoto K, Inui T, Sada M, Honda K, Tamura M, et al. Serum sST2 levels predict severe exacerbation of asthma. Respir Res. 2018;19:169 pubmed publisher |
Cottagiri M, Nyandjo M, Stephens M, Mantilla J, Saito H, Mackay I, et al. In drug-induced, immune-mediated hepatitis, interleukin-33 reduces hepatitis and improves survival independently and as a consequence of FoxP3+ T-cell activity. Cell Mol Immunol. 2018;: pubmed publisher |
Rivière E, Sellam J, Pascaud J, Ravaud P, Gottenberg J, Mariette X. Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis. Arthritis Res Ther. 2018;20:122 pubmed publisher |
Wei Z, Li Y, Huang S, Tan Z. Genetic variants in IL-33/ST2 pathway with the susceptibility to hepatocellular carcinoma in a Chinese population. Cytokine. 2018;: pubmed publisher |
La Rosa F, Saresella M, Baglio F, Piancone F, Marventano I, Calabrese E, et al. Immune and Imaging Correlates of Mild Cognitive Impairment Conversion to Alzheimer's Disease. Sci Rep. 2017;7:16760 pubmed publisher |
Timóteo R, da Silva M, Miguel C, Silva D, Catarino J, Rodrigues Junior V, et al. Th1/Th17-Related Cytokines and Chemokines and Their Implications in the Pathogenesis of Pemphigus Vulgaris. Mediators Inflamm. 2017;2017:7151285 pubmed publisher |
Maddur M, Stephen Victor E, Das M, Prakhar P, Sharma V, Singh V, et al. Regulatory T cell frequency, but not plasma IL-33 levels, represents potential immunological biomarker to predict clinical response to intravenous immunoglobulin therapy. J Neuroinflammation. 2017;14:58 pubmed publisher |
Lee J, Chang H, Lee H, Jung C, Bae D, Song H, et al. Upregulation of interleukin-33 and thymic stromal lymphopoietin levels in the lungs of idiopathic pulmonary fibrosis. BMC Pulm Med. 2017;17:39 pubmed publisher |
Shen J, Shang Q, Wong C, Li E, Kun E, Cheng I, et al. Carotid plaque and bone density and microarchitecture in psoriatic arthritis: the correlation with soluble ST2. Sci Rep. 2016;6:32116 pubmed publisher |
Ketelaar M, Nawijn M, Shaw D, Koppelman G, Sayers I. The challenge of measuring IL-33 in serum using commercial ELISA: lessons from asthma. Clin Exp Allergy. 2016;46:884-7 pubmed publisher |
Bu X, Zhang T, Wang C, Ren T, Wen Z. IL-33 reflects dynamics of disease activity in patients with autoimmune hemolytic anemia by regulating autoantibody production. J Transl Med. 2015;13:381 pubmed publisher |
Guerrero C, Arrieta A, Ramirez N, Rodríguez L, Vega R, Bosch I, et al. High plasma levels of soluble ST2 but not its ligand IL-33 is associated with severe forms of pediatric dengue. Cytokine. 2013;61:766-71 pubmed publisher |
